{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:25:45Z","timestamp":1793330745141,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00018-021-04007-1","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T07:02:39Z","timestamp":1635663759000},"page":"7491-7503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mitigating the pro-oxidant state and melanogenesis of Retinitis pigmentosa: by counteracting mitochondrial dysfunction"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-2620","authenticated-orcid":false,"given":"Giovanni","family":"Pagano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico V.","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Lyakhovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Trifuoggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,31]]},"reference":[{"key":"4007_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mito.2017.03.006","volume":"36","author":"E Lefevere","year":"2017","unstructured":"Lefevere E, Toft-Kehler AK, Vohra R, Kolko M, Moons L, Van Hove I (2017) Mitochondrial dysfunction underlying outer retinal diseases. Mitochondrion 36:66\u201376. https:\/\/doi.org\/10.1016\/j.mito.2017.03.006","journal-title":"Mitochondrion"},{"key":"4007_CR2","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.cub.2008.10.029","volume":"18","author":"H Okawa","year":"2008","unstructured":"Okawa H, Sampath AP, Laughlin SB, Fain GL (2008) ATP consumption by mammalian rod photoreceptors in darkness and in light. Curr Biol 18:1917\u20131921. https:\/\/doi.org\/10.1016\/j.cub.2008.10.029","journal-title":"Curr Biol"},{"key":"4007_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cell.2009.09.029","volume":"139","author":"KW Yau","year":"2009","unstructured":"Yau KW, Hardie RC (2009) Phototransduction motifs and variations. Cell 139:246\u2013264. https:\/\/doi.org\/10.1016\/j.cell.2009.09.029","journal-title":"Cell"},{"key":"4007_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.10.002","volume":"62","author":"D Athanasiou","year":"2018","unstructured":"Athanasiou D, Aguila M, Bellingham J, Li W, McCulley C, Reeves PJ, Cheetham ME (2018) The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy. Prog Retin Eye Res 62:1\u201323","journal-title":"Prog Retin Eye Res"},{"issue":"9549","key":"4007_CR5","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368(9549):1795\u20131809. https:\/\/doi.org\/10.1016\/S0140-6736(06)69740-7","journal-title":"Lancet"},{"key":"4007_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-319-75402-4_23","volume":"1074","author":"MT Massengill","year":"2018","unstructured":"Massengill MT, Ahmed CM, Lewin AS, Ildefonso CJ (2018) Neuroinflammation in retinitis pigmentosa, diabetic retinopathy, and age-related macular degeneration: a minireview. Adv Exp Med Biol 1074:185\u2013191. https:\/\/doi.org\/10.1007\/978-3-319-75402-4_23","journal-title":"Adv Exp Med Biol"},{"key":"4007_CR7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/aos.13141","volume":"94","author":"DS Narayan","year":"2016","unstructured":"Narayan DS, Wood JP, Chidlow G, Casson RJ (2016) A review of the mechanisms of cone degeneration in retinitis pigmentosa. Acta Ophthalmol 94:748\u2013754. https:\/\/doi.org\/10.1111\/aos.13141","journal-title":"Acta Ophthalmol"},{"key":"4007_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/541230","volume":"2014","author":"G Pagano","year":"2014","unstructured":"Pagano G, Aiello Talamanca A, Castello G, Cordero MD, d\u2019Ischia M, Gadaleta MN, Pallard\u00f3 FV, Petrovi\u0107 S, Tiano L, Zatterale A (2014) Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward a rational design of chemoprevention strategies by means of mitochondrial nutrients. Oxid Med Cell Longev 2014:541230. https:\/\/doi.org\/10.1155\/2014\/541230","journal-title":"Oxid Med Cell Longev"},{"key":"4007_CR9","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.3390\/ijms21197060","volume":"21","author":"G Pagano","year":"2020","unstructured":"Pagano G, Pallard\u00f3 FV, Lyakhovich A, Tiano L, Fittipaldi MR, Toscanesi M, Trifuoggi M (2020) Aging-related disorders and mitochondrial dysfunction: a critical review for prospect mitoprotective strategies based on mitochondrial nutrient mixtures. Int J Mol Sci 21:7060. https:\/\/doi.org\/10.3390\/ijms21197060","journal-title":"Int J Mol Sci"},{"key":"4007_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/antiox9040313","volume":"9","author":"C Espin\u00f3s","year":"2020","unstructured":"Espin\u00f3s C, Galindo MI, Garc\u00eda-Gimeno MA, Ib\u00e1\u00f1ez-Cabellos JS, Mart\u00ednez-Rubio D, Mill\u00e1n JM, Rodrigo R, Sanz P, Seco-Cervera M, Sevilla T, Tapia A, Pallard\u00f3 FV (2020) Oxidative stress, a crossroad between rare diseases and neurodegeneration. Antioxidants (Basel) 9:313. https:\/\/doi.org\/10.3390\/antiox9040313","journal-title":"Antioxidants (Basel)"},{"key":"4007_CR11","doi-asserted-by":"publisher","unstructured":"L\u00e9veillard T, Mohand-Sa\u0131 \u0308d S, Lorentz O, Hicks D, Fintz AC, Cl\u00e9rin E, Simonutti M, Forster V, Cavusoglu N, Chalmel F, Doll\u00e9 P, Poch O, Lambrou G, Sahel JA (2004) Identification and characterization of rod-derived cone viability factor. Nat Genet 36:755\u2013759. https:\/\/doi.org\/10.1038\/ng1386","DOI":"10.1038\/ng1386"},{"key":"4007_CR12","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1074\/jbc.R111.304428","volume":"287","author":"C Punzo","year":"2012","unstructured":"Punzo C, Xiong W, Cepko CL (2012) Loss of daylight vision in retinal degeneration: are oxidative stress and metabolic dysregulation to blame? J Biol Chem 287:1642\u20131648. https:\/\/doi.org\/10.1074\/jbc.R111.304428","journal-title":"J Biol Chem"},{"key":"4007_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1471-4159.2007.04839.x","volume":"203","author":"J Shen","year":"2005","unstructured":"Shen J, Yang X, Dong A, Petters RM, Wong F, Campochiaro PA (2005) Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol 203:457\u2013464. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04839.x","journal-title":"J Cell Physiol"},{"key":"4007_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1471-4159.2009.06195.x","volume":"110","author":"S Usui","year":"2009","unstructured":"Usui S, Oveson BC, Lee SY, Jo YJ, Yoshida T, Miki A, Miki K, Iwase T, Lu L, Campochiaro PA (2009) NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. J Neurochem 110:1028\u20131037. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06195.x","journal-title":"J Neurochem"},{"key":"4007_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/WNR.0b013e3280c1e344","volume":"18","author":"P Ahuja-Jensen","year":"2007","unstructured":"Ahuja-Jensen P, Johnsen-Soriano S, Ahuja S, Bosch-Morell F, Sancho-Tello M, Romero FJ, Abrahamson M, van Veen T (2007) Low glutathione peroxidase in rd1 mouse retina increases oxidative stress and proteases. NeuroReport 18:797\u2013801. https:\/\/doi.org\/10.1097\/WNR.0b013e3280c1e344","journal-title":"NeuroReport"},{"key":"4007_CR16","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1073\/pnas.0604056103","volume":"103","author":"K Komeima","year":"2006","unstructured":"Komeima K, Rogers BS, Lu L, Campochiaro PA (2006) Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci USA 103:11300\u201311305. https:\/\/doi.org\/10.1073\/pnas.0604056103","journal-title":"Proc Natl Acad Sci USA"},{"key":"4007_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrd.2018.174","volume":"17","author":"MP Murphy","year":"2018","unstructured":"Murphy MP, Hartley RC (2018) Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov 17:865\u2013886. https:\/\/doi.org\/10.1038\/nrd.2018.174","journal-title":"Nat Rev Drug Discov"},{"key":"4007_CR18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/jcp.21152","volume":"213","author":"K Komeima","year":"2007","unstructured":"Komeima K, Rogers BS, Campochiaro PA (2007) Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa. J Cell Physiol 213:809\u2013815. https:\/\/doi.org\/10.1002\/jcp.21152","journal-title":"J Cell Physiol"},{"key":"4007_CR19","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/jcp.22508","volume":"226","author":"SY Lee","year":"2011","unstructured":"Lee SY, Usui S, Zafar AB, Oveson B, Jo YJ, Lu L, Masoudi S, Campochiaro PA (2011) N-Acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa. J Cell Physiol 226:1843\u20131849. https:\/\/doi.org\/10.1002\/jcp.22508","journal-title":"J Cell Physiol"},{"key":"4007_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/mt.2009.47","volume":"17","author":"S Usui","year":"2009","unstructured":"Usui S, Komeima K, Lee SY, Jo YJ, Ueno S, Rogers BS, Wu Z, Shen J, Lu L, Oveson BC, Rabinovitch PS, Campochiaro PA (2009) Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol Ther 17:778\u2013786. https:\/\/doi.org\/10.1038\/mt.2009.47","journal-title":"Mol Ther"},{"key":"4007_CR21","volume-title":"GeneReviews\u00ae [Internet]","author":"PF Chinnery","year":"2000","unstructured":"Chinnery PF (2000) Mitochondrial disorders overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"4007_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/164_2016_91","volume":"242","author":"TC Hohman","year":"2017","unstructured":"Hohman TC (2017) Hereditary retinal dystrophy. Handb Exp Pharmacol 242:337\u2013367. https:\/\/doi.org\/10.1007\/164_2016_91","journal-title":"Handb Exp Pharmacol"},{"key":"4007_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphys.2018.01008","volume":"9","author":"ML Moreno","year":"2018","unstructured":"Moreno ML, M\u00e9rida S, Bosch-Morell F, Miranda M, Villar VM (2018) Autophagy dysfunction and oxidative stress, two related mechanisms implicated in retinitis pigmentosa. Front Physiol 9:1008. https:\/\/doi.org\/10.3389\/fphys.2018.01008","journal-title":"Front Physiol"},{"key":"4007_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/B978-0-12-802395-2.00010-9","volume":"145","author":"MJ Molnar","year":"2017","unstructured":"Molnar MJ, Kovacs GG (2017) Mitochondrial diseases. Handb Clin Neurol 145:147\u2013155. https:\/\/doi.org\/10.1016\/B978-0-12-802395-2.00010-9","journal-title":"Handb Clin Neurol"},{"key":"4007_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/joim.13054","volume":"287","author":"S Rahman","year":"2020","unstructured":"Rahman S (2020) Mitochondrial disease in children. J Intern Med 287:609\u2013633. https:\/\/doi.org\/10.1111\/joim.13054","journal-title":"J Intern Med"},{"key":"4007_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/antiox10060848","volume":"10","author":"CE Gallenga","year":"2021","unstructured":"Gallenga CE, Lonardi M, Pacetti S, Violanti SS, Tassinari P, Di Virgilio F, Tognon M, Perri P (2021) Molecular mechanisms related to oxidative stress in retinitis pigmentosa. Antioxidants (Basel) 10:848. https:\/\/doi.org\/10.3390\/antiox10060848","journal-title":"Antioxidants (Basel)"},{"key":"4007_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","volume":"66","author":"SK Verbakel","year":"2018","unstructured":"Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, Hoyng CB, Roepman R, Klevering BJ (2018) Non-syndromic retinitis pigmentosa. Prog Retin Eye Res 66:157\u2013186. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.03.005","journal-title":"Prog Retin Eye Res"},{"key":"4007_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214639","volume":"14","author":"J Mitchell","year":"2019","unstructured":"Mitchell J, Balem F, Tirupula K, Man D, Dhiman HK, Yanamala N, Ollesch J, Planas-Iglesias J, Jennings BJ, Gerwert K, Iannaccone A, Klein-Seetharaman J (2019) Comparison of the molecular properties of retinitis pigmentosa P23H and N15S amino acid replacements in rhodopsin. PLoS ONE 14:e0214639. https:\/\/doi.org\/10.1371\/journal.pone.0214639","journal-title":"PLoS ONE"},{"key":"4007_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.brainres.2016.04.021","volume":"1648","author":"P Chan","year":"2016","unstructured":"Chan P, Stolz J, Kohl S, Chiang WC, Lin JH (2016) Endoplasmic reticulum stress in human photoreceptor diseases. Brain Res 1648:538\u2013541. https:\/\/doi.org\/10.1016\/j.brainres.2016.04.021","journal-title":"Brain Res"},{"key":"4007_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/BJ20111004","volume":"441","author":"DL Duricka","year":"2012","unstructured":"Duricka DL, Brown RL, Varnum MD (2012) Defective trafficking of cone photoreceptor CNG channels induces the unfolded protein response and ER-stress-associated cell death. Biochem J 441:685\u2013696. https:\/\/doi.org\/10.1042\/BJ20111004","journal-title":"Biochem J"},{"key":"4007_CR31","doi-asserted-by":"publisher","first-page":"46580","DOI":"10.1074\/jbc.M406685200","volume":"279","author":"JL Campian","year":"2004","unstructured":"Campian JL, Qian M, Gao X, Eaton JW (2004) Oxygen tolerance and coupling of mitochondrial electron transport. J Biol Chem 279:46580\u201346587. https:\/\/doi.org\/10.1074\/jbc.M406685200","journal-title":"J Biol Chem"},{"key":"4007_CR32","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphys.2018.01008","volume":"9","author":"ML Moreno","year":"2018","unstructured":"Moreno ML, Merida S, Bosch-Morell F, Miranda M, Villar VM (2018) Autophagy dysfunction and oxidative stress, two related mechanisms implicated in retinitis pigmentosa. Front Physiol 9:1008. https:\/\/doi.org\/10.3389\/fphys.2018.01008","journal-title":"Front Physiol"},{"key":"4007_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/hmg\/ddq467","volume":"20","author":"D Vlachantoni","year":"2011","unstructured":"Vlachantoni D, Bramall AN, Murphy MP, Taylor RW, Shu X, Tulloch B, Van Veen T, Turnbull DM, McInnes RR, Wright AF (2011) Evidence of severe mitochondrial oxidative stress and a protective effect of low oxygen in mouse models of inherited photoreceptor degeneration. Hum Mol Genet 20:322\u2013335. https:\/\/doi.org\/10.1093\/hmg\/ddq467","journal-title":"Hum Mol Genet"},{"key":"4007_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cellsig.2013.12.008","volume":"26","author":"OS Sizova","year":"2014","unstructured":"Sizova OS, Shinde VM, Lenox AR, Gorbatyuk MS (2014) Modulation of cellular signaling pathways in P23H rhodopsin photoreceptors. Cell Signal 26:665\u2013672. https:\/\/doi.org\/10.1016\/j.cellsig.2013.12.008","journal-title":"Cell Signal"},{"key":"4007_CR35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.14670\/HH-25.933","volume":"25","author":"A Tsubura","year":"2010","unstructured":"Tsubura A, Yoshizawa K, Kuwata M, Uehara N (2010) Animal models for retinitis pigmentosa induced by MNU; disease progression, mechanisms and therapeutic trials. Histol Histopathol 25:933\u2013944. https:\/\/doi.org\/10.14670\/HH-25.933","journal-title":"Histol Histopathol"},{"key":"4007_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.emboj.7601975","volume":"27","author":"S Oka","year":"2008","unstructured":"Oka S, Ohno M, Tsuchimoto D, Sakumi K, Furuichi M, Nakabeppu Y (2008) Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J 27:421\u2013432. https:\/\/doi.org\/10.1038\/sj.emboj.7601975","journal-title":"EMBO J"},{"key":"4007_CR37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1006\/excr.1998.4421","volume":"248","author":"RJ Carmody","year":"1999","unstructured":"Carmody RJ, McGowan AJ, Cotter TG (1999) Reactive oxygen species as mediators of photoreceptor apoptosis in vitro. Exp Cell Res 248:520\u2013530. https:\/\/doi.org\/10.1006\/excr.1998.4421","journal-title":"Exp Cell Res"},{"key":"4007_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sj.cdd.4400646","volume":"7","author":"RJ Carmody","year":"2000","unstructured":"Carmody RJ, Cotter TG (2000) Oxidative stress induces caspase-independent retinal apoptosis in vitro. Cell Death Differ 7:282\u2013291. https:\/\/doi.org\/10.1038\/sj.cdd.4400646","journal-title":"Cell Death Differ"},{"key":"4007_CR39","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.freeradbiomed.2011.06.010","volume":"51","author":"S Usui","year":"2011","unstructured":"Usui S, Oveson BC, Iwase T, Lu L, Lee SY, Jo YJ, Wu Z, Choi EY, Samulski RJ, Campochiaro PA (2011) Overexpression of SOD in retina: need for increase in H2O2-detoxifying enzyme in same cellular compartment. Free Radic Biol Med 51:1347\u20131354. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.06.010","journal-title":"Free Radic Biol Med"},{"key":"4007_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/jnc.12307","volume":"126","author":"S Vogler","year":"2013","unstructured":"Vogler S, Grosche A, Pannicke T, Ulbricht E, Wiedemann P, Reichenbach A, Bringmann A (2013) Hypoosmotic and glutamate-induced swelling of bipolar cells in the rat retina: comparison with swelling of M\u00fcller glial cells. J Neurochem 126:372\u2013381. https:\/\/doi.org\/10.1111\/jnc.12307","journal-title":"J Neurochem"},{"key":"4007_CR41","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s11064-016-1894-0","volume":"41","author":"S Vogler","year":"2016","unstructured":"Vogler S, Pannicke T, Hollborn M, Kolibabka M, Wiedemann P, Reichenbach A, Hammes HP, Bringmann A (2016) Impaired purinergic regulation of the glial (M\u00fcller) cell volume in the retina of transgenic rats expressing defective polycystin-2. Neurochem Res 41:1784\u20131796. https:\/\/doi.org\/10.1007\/s11064-016-1894-0","journal-title":"Neurochem Res"},{"key":"4007_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mus.20688","volume":"35","author":"MC Rodriguez","year":"2007","unstructured":"Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA (2007) Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 35:235\u2013242. https:\/\/doi.org\/10.1002\/mus.20688","journal-title":"Muscle Nerve"},{"key":"4007_CR43","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.addr.2008.05.001","volume":"60","author":"MA Tarnopolsky","year":"2008","unstructured":"Tarnopolsky MA (2008) The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev 60:1561\u20131567. https:\/\/doi.org\/10.1016\/j.addr.2008.05.001","journal-title":"Adv Drug Deliv Rev"},{"key":"4007_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/10284150500047161","volume":"8","author":"J Liu","year":"2005","unstructured":"Liu J, Ames BN (2005) Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer\u2019s disease, and Parkinson\u2019s disease. Nutr Neurosci 8:67\u201389. https:\/\/doi.org\/10.1080\/10284150500047161","journal-title":"Nutr Neurosci"},{"key":"4007_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mad.2010.04.005","volume":"131","author":"BN Ames","year":"2010","unstructured":"Ames BN (2010) Optimal micronutrients delay mitochondrial decay and age-associated diseases. Mech Ageing Dev 131:473\u2013479. https:\/\/doi.org\/10.1016\/j.mad.2010.04.005","journal-title":"Mech Ageing Dev"},{"key":"4007_CR46","doi-asserted-by":"publisher","first-page":"8731","DOI":"10.1073\/pnas.91.19.8731","volume":"91","author":"R Luft","year":"1994","unstructured":"Luft R (1994) The development of mitochondrial medicine. Proc Natl Acad Sci USA 91:8731\u20138738. https:\/\/doi.org\/10.1073\/pnas.91.19.8731","journal-title":"Proc Natl Acad Sci USA"},{"key":"4007_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.preteyeres.2017.08.004","volume":"62","author":"PA Campochiaro","year":"2018","unstructured":"Campochiaro PA, Mir TA (2018) The mechanism of cone cell death in retinitis pigmentosa. Prog Retin Eye Res 62:24\u201337. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.08.004","journal-title":"Prog Retin Eye Res"},{"key":"4007_CR48","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.2174\/0929867324666170801100516","volume":"24","author":"X Zhang","year":"2017","unstructured":"Zhang X, Tohari AM, Marcheggiani F, Zhou X, Reilly J, Tiano L, Shu X (2017) Therapeutic potential of co-enzyme Q10 in retinal diseases. Curr Med Chem 24:4329\u20134339. https:\/\/doi.org\/10.2174\/0929867324666170801100516","journal-title":"Curr Med Chem"},{"key":"4007_CR49","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.clnu.2018.08.032","volume":"38","author":"E Wesselink","year":"2019","unstructured":"Wesselink E, Koekkoek WAC, Grefte S, Witkamp RF, van Zanten ARH (2019) Feeding mitochondria: potential role of nutritional components to improve critical illness convalescence. Clin Nutr 38:982\u2013995. https:\/\/doi.org\/10.1016\/j.clnu.2018.08.032","journal-title":"Clin Nutr"},{"key":"4007_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/antiox8030053","volume":"8","author":"V Hern\u00e1ndez-Rabaza","year":"2019","unstructured":"Hern\u00e1ndez-Rabaza V, L\u00f3pez-Pedrajas R, Almansa I (2019) Progesterone, lipoic acid, and sulforaphane as promising antioxidants for retinal diseases: a review. Antioxidants (Basel) 8:53. https:\/\/doi.org\/10.3390\/antiox8030053","journal-title":"Antioxidants (Basel)"},{"key":"4007_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/antiox9010082","volume":"9","author":"G Pagano","year":"2020","unstructured":"Pagano G, Pallard\u00f3 FV, Porto B, Fittipaldi MR, Lyakhovich A, Trifuoggi M (2020) Mitoprotective clinical strategies in type 2 diabetes and Fanconi anemia patients: suggestions for clinical management of mitochondrial dysfunction. Antioxidants (Basel) 9:82. https:\/\/doi.org\/10.3390\/antiox9010082","journal-title":"Antioxidants (Basel)"},{"key":"4007_CR52","first-page":"205","volume":"111","author":"P Palacka","year":"2010","unstructured":"Palacka P, Kucharska J, Murin J, Dostalova K, Okkelova A, Cizova M, Waczulikova I, Moricova S, Gvozdjakova A (2010) Complementary therapy in diabetic patients with chronic complications: a pilot study. Bratisl Lek Listy 111:205\u2013211 (PMID: 20586147)","journal-title":"Bratisl Lek Listy"},{"key":"4007_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jdi.13401","volume":"12","author":"D Ziegler","year":"2021","unstructured":"Ziegler D, Papanas N, Schnell O, Nguyen BDT, Nguyen KT, Kulkantrakorn K, Deerochanawong C (2021) Current concepts in the management of diabetic polyneuropathy. J Diabetes Investig 12:464\u2013475. https:\/\/doi.org\/10.1111\/jdi.13401","journal-title":"J Diabetes Investig"},{"key":"4007_CR54","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.3390\/nu12113254","volume":"12","author":"T Didangelos","year":"2020","unstructured":"Didangelos T, Karlafti E, Kotzakioulafi E, Kontoninas Z, Margaritidis C, Giannoulaki P, Kantartzis K (2020) Efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, Vitamin B12, and carnitine for 12 months in patients with diabetic neuropathy. Nutrients 12:3254. https:\/\/doi.org\/10.3390\/nu12113254","journal-title":"Nutrients"},{"key":"4007_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1172-7-28","volume":"7","author":"F Ponte","year":"2012","unstructured":"Ponte F, Sousa R, Fernandes AP, Gon\u00e7alves C, Barbot J, Carvalho F, Porto B (2012) Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of \u03b1-lipoic acid and N-acetylcysteine. Orphanet J Rare Dis 7:28. https:\/\/doi.org\/10.1186\/1750-1172-7-28","journal-title":"Orphanet J Rare Dis"},{"key":"4007_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000356145","volume":"21","author":"M Khalili","year":"2014","unstructured":"Khalili M, Azimi A, Izadi V, Eghtesadi S, Mirshafiey A, Sahraian MA, Motevalian A, Norouzi A, Sanoobar M, Eskandari G, Farhoudi M, Amani F (2014) Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial. NeuroImmunoModulation 21:91\u2013296. https:\/\/doi.org\/10.1159\/000356145","journal-title":"NeuroImmunoModulation"},{"key":"4007_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/03946320090220S309","volume":"22","author":"M Ranieri","year":"2009","unstructured":"Ranieri M, Sciuscio M, Cortese AM, Santamato A, di Teo L, Ianieri G, Bellomo RG, Stasi M, Megna M (2009) The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. Int J Immunopathol Pharmacol 22:45\u201350. https:\/\/doi.org\/10.1177\/03946320090220S309","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4007_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/JAD-130722","volume":"38","author":"L Shinto","year":"2014","unstructured":"Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J (2014) A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer\u2019s disease. J Alzheimers Dis 38:111\u2013120. https:\/\/doi.org\/10.3233\/JAD-130722","journal-title":"J Alzheimers Dis"},{"key":"4007_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jcpt.12784","volume":"44","author":"S Hosseinpour-Arjmand","year":"2019","unstructured":"Hosseinpour-Arjmand S, Amirkhizi F, Ebrahimi-Mameghani M (2019) The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 44:258\u2013267. https:\/\/doi.org\/10.1111\/jcpt.12784","journal-title":"J Clin Pharm Ther"},{"key":"4007_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1524-6175.2007.06052.x","volume":"9","author":"CJ McMackin","year":"2007","unstructured":"McMackin CJ, Widlansky ME, Hamburg NM, Huang AL, Weller S, Holbrook M, Gokce N, Hagen TM, Keaney JF Jr, Vita JA (2007) Effect of combined treatment with alpha-lipoic acid and acetyl-l-carnitine on vascular function and blood pressure in patients with coronary artery disease. J Clin Hypertens 9:249\u2013255. https:\/\/doi.org\/10.1111\/j.1524-6175.2007.06052.x","journal-title":"J Clin Hypertens"},{"key":"4007_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1620\/tjem.229.45","volume":"229","author":"RJ Li","year":"2013","unstructured":"Li RJ, Ji WQ, Pang JJ, Wang JL, Chen YG, Zhang Y (2013) Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome. Tohoku J Exp Med 229:45\u201351. https:\/\/doi.org\/10.1620\/tjem.229.45","journal-title":"Tohoku J Exp Med"},{"key":"4007_CR62","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.hlc.2010.06.659","volume":"19","author":"JY Leong","year":"2010","unstructured":"Leong JY, van der Merwe J, Pepe S, Bailey M, Perkins A, Lymbury R, Esmore D, Marasco S, Rosenfeldt F (2010) Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomised trial. Heart Lung Circ 19:584\u2013591. https:\/\/doi.org\/10.1016\/j.hlc.2010.06.659","journal-title":"Heart Lung Circ"},{"key":"4007_CR63","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/nu12041098","volume":"12","author":"J Sabbatinelli","year":"2020","unstructured":"Sabbatinelli J, Orlando P, Galeazzi R, Silvestri S, Cirilli I, Marcheggiani F, Dludla PV, Giuliani A, Bonfigli AR, Mazzanti L, Olivieri F, Antonicelli R, Tiano L (2020) Ubiquinol ameliorates endothelial dysfunction in subjects with mild-to-moderate dyslipidemia: a randomized clinical trial. Nutrients 12:1098. https:\/\/doi.org\/10.3390\/nu12041098","journal-title":"Nutrients"},{"key":"4007_CR64","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","volume":"2","author":"SA Mortensen","year":"2014","unstructured":"Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP, Q-SYMBIO Study Investigators (2014) The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail 2:641\u2013649. https:\/\/doi.org\/10.1016\/j.jchf.2014.06.008","journal-title":"JACC Heart Fail"},{"issue":"4","key":"4007_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193120","volume":"13","author":"U Alehagen","year":"2018","unstructured":"Alehagen U, Aaseth J, Alexander J, Johansson P (2018) Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: a validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly. PLoS ONE 13(4):e0193120. https:\/\/doi.org\/10.1371\/journal.pone.0193120","journal-title":"PLoS ONE"},{"key":"4007_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1179\/1476830515Y.0000000002","volume":"19","author":"M Sanoobar","year":"2016","unstructured":"Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F (2016) Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutr Neurosci 19:138\u2013143. https:\/\/doi.org\/10.1179\/1476830515Y.0000000002","journal-title":"Nutr Neurosci"},{"key":"4007_CR67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nmd.2019.10.008","volume":"30","author":"L Servais","year":"2020","unstructured":"Servais L, Straathof CSM, Schara U, Klein A, Leinonen M, Hasham S, Meier T, De Waele L, Gordish-Dressman H, McDonald CM, Mayer OH, Voit T, Mercuri E, Buyse GM, SYROS and CINRG DNHS Investigators (2020) Long-term data with idebenone on respiratory function outcomes in patients with Duchenne muscular dystrophy. Neuromuscul Disord 30:5\u201316. https:\/\/doi.org\/10.1016\/j.nmd.2019.10.008","journal-title":"Neuromuscul Disord"},{"key":"4007_CR68","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1089\/ars.2013.5198","volume":"20","author":"MD Cordero","year":"2014","unstructured":"Cordero MD, Alcocer-G\u00f3mez E, Culic O, Carri\u00f3n AM, de Miguel M, D\u00edaz-Parrado E, P\u00e9rez-Villegas EM, Bull\u00f3n P, Battino M, S\u00e1nchez-Alcazar JA (2014) NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal 20:1169\u20131180. https:\/\/doi.org\/10.1089\/ars.2013.5198","journal-title":"Antioxid Redox Signal"},{"key":"4007_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/S0007114518001241","volume":"120","author":"CH Yen","year":"2018","unstructured":"Yen CH, Chu YJ, Lee BJ, Lin YC, Lin PT (2018) Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial. Br J Nutr 120:57\u201363. https:\/\/doi.org\/10.1017\/S0007114518001241","journal-title":"Br J Nutr"},{"key":"4007_CR70","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.biopha.2018.06.076","volume":"105","author":"A Mazza","year":"2018","unstructured":"Mazza A, Lenti S, Schiavon L, Di Giacomo E, Tomasi M, Manunta R, Torin G, Townsend DM, Rubello D (2018) Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome. Biomed Pharmacother 105:992\u2013996. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.076","journal-title":"Biomed Pharmacother"},{"key":"4007_CR71","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/09513590.2017.1290071","volume":"33","author":"H Jamilian","year":"2017","unstructured":"Jamilian H, Jamilian M, Samimi M, Afshar Ebrahimi F, Rahimi M, Bahmani F, Aghababayan S, Kouhi M, Shahabbaspour S, Asemi Z (2017) Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Gynecol Endocrinol 33:442\u2013447. https:\/\/doi.org\/10.1080\/09513590.2017.1290071","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"4007_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119578","volume":"10","author":"S Fukuda","year":"2015","unstructured":"Fukuda S, Koyama H, Kondo K, Fujii H, Hirayama Y, Tabata T, Okamura M, Yamakawa T, Okada S, Hirata S, Kiyama H, Kajimoto O, Watanabe Y, Inaba M, Nishizawa Y (2015) Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial. PLoS ONE 10(3):e0119578. https:\/\/doi.org\/10.1371\/journal.pone.0119578","journal-title":"PLoS ONE"},{"key":"4007_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41430-018-0348-y","volume":"73","author":"T Maruyama","year":"2019","unstructured":"Maruyama T, Maruyama N, Higuchi T, Nagura C, Takashima H, Kitai M, Utsunomiya K, Tei R, Furukawa T, Yamazaki T, Okawa E, Ando H, Kikuchi F, Abe M (2019) Efficacy of l-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial. Eur J Clin Nutr 73:293\u2013301. https:\/\/doi.org\/10.1038\/s41430-018-0348-y","journal-title":"Eur J Clin Nutr"},{"key":"4007_CR74","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10557-012-6408-y","volume":"26","author":"S De Marchi","year":"2012","unstructured":"De Marchi S, Zecchetto S, Rigoni A, Prior M, Fondrieschi L, Scuro A, Rulfo F, Arosio E (2012) Propionyl-l-carnitine improves endothelial function, microcirculation and pain management in critical limb ischemia. Cardiovasc Drugs Ther 26:401\u2013408. https:\/\/doi.org\/10.1007\/s10557-012-6408-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"4007_CR75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1358863X12442264","volume":"17","author":"NA Goldenberg","year":"2012","unstructured":"Goldenberg NA, Krantz MJ, Hiatt WR (2012) l-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial. Vasc Med 17:145\u2013154. https:\/\/doi.org\/10.1177\/1358863X12442264","journal-title":"Vasc Med"},{"key":"4007_CR76","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1089\/jir.2011.0010","volume":"31","author":"M Malaguarnera","year":"2011","unstructured":"Malaguarnera M, Vacante M, Bertino G, Neri S, Malaguarnera M, Gargante MP, Motta M, Lupo L, Chisari G, Bruno CM, Pennisi G, Bella R (2011) The supplementation of acetyl-l-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-\u03b1 2b plus ribavirin. J Interferon Cytokine Res 31:653\u2013659. https:\/\/doi.org\/10.1089\/jir.2011.0010","journal-title":"J Interferon Cytokine Res"},{"key":"4007_CR77","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fphar.2018.00469","volume":"9","author":"DT Ram\u00edrez-Lamelas","year":"2018","unstructured":"Ram\u00edrez-Lamelas DT, Benlloch-Navarro S, L\u00f3pez-Pedrajas R, Gimeno-Hern\u00e1ndez R, Olivar T, Silvestre D, Miranda M (2018) Lipoic acid and progesterone alone or in combination ameliorate retinal degeneration in an experimental model of hereditary retinal degeneration. Front Pharmacol 9:469. https:\/\/doi.org\/10.3389\/fphar.2018.00469","journal-title":"Front Pharmacol"},{"issue":"30","key":"4007_CR78","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1073\/pnas.0604056103","volume":"103","author":"K Komeima","year":"2006","unstructured":"Komeima K, Rogers BS, Lu L, Campochiaro PA (2006) Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci U S A 103(30):11300\u201311305. https:\/\/doi.org\/10.1073\/pnas.0604056103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4007_CR79","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.neuroscience.2006.12.034","volume":"145","author":"MM Sanz","year":"2007","unstructured":"Sanz MM, Johnson LE, Ahuja S, Ekstr\u00f6m PA, Romero J, van Veen T (2007) Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neuroscience 145:1120\u20131129. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.12.034","journal-title":"Neuroscience"},{"key":"4007_CR80","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1167\/iovs.14-15025","volume":"55","author":"L Zhao","year":"2014","unstructured":"Zhao L, Wang C, Song D, Li Y, Song Y, Su G, Dunaief JL (2014) Systemic administration of the antioxidant\/iron chelator \u03b1-lipoic acid protects against light-induced photoreceptor degeneration in the mouse retina. Invest Ophthalmol Vis Sci 55:5979\u20135988. https:\/\/doi.org\/10.1167\/iovs.14-15025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4007_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2015.10.005","volume":"145","author":"D Song","year":"2016","unstructured":"Song D, Song J, Wang C, Li Y, Dunaief JL (2016) Berberine protects against light-induced photoreceptor degeneration in the mouse retina. Exp Eye Res 145:1\u20139. https:\/\/doi.org\/10.1016\/j.exer.2015.10.005","journal-title":"Exp Eye Res"},{"key":"4007_CR82","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fnins.2019.00461","volume":"13","author":"I Piano","year":"2019","unstructured":"Piano I, D\u2019Antongiovanni V, Testai L, Calderone V, Gargini C (2019) a nutraceutical strategy to slowing down the progression of cone death in an animal model of retinitis pigmentosa. Front Neurosci 13:461. https:\/\/doi.org\/10.3389\/fnins.2019.00461","journal-title":"Front Neurosci"},{"key":"4007_CR83","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.8.6.20","volume":"8","author":"T Okamoto","year":"2019","unstructured":"Okamoto T, Kawashima H, Osada H, Toda E, Homma K, Nagai N, Imai Y, Tsubota K, Ozawa Y (2019) Dietary spirulina supplementation protects visual function from photostress by suppressing retinal neurodegeneration in mice. Transl Vis Sci Technol 8:20. https:\/\/doi.org\/10.1167\/tvst.8.6.20","journal-title":"Transl Vis Sci Technol"},{"key":"4007_CR84","doi-asserted-by":"publisher","first-page":"20382","DOI":"10.1038\/s41598-020-77290-w","volume":"10","author":"S Gopalakrishnan","year":"2020","unstructured":"Gopalakrishnan S, Mehrvar S, Maleki S, Schmitt H, Summerfelt P, Dubis AM, Abroe B, Connor TB Jr, Carroll J, Huddleston W, Ranji M, Eells JT (2020) Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa. Sci Rep 10:20382. https:\/\/doi.org\/10.1038\/s41598-020-77290-w","journal-title":"Sci Rep"},{"key":"4007_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109690","volume":"122","author":"Q Song","year":"2020","unstructured":"Song Q, Zhao Y, Li Q, Han X, Duan J (2020) Puerarin protects against iron overload-induced retinal injury through regulation of iron-handling proteins. Biomed Pharmacother 122:109690. https:\/\/doi.org\/10.1016\/j.biopha.2019.109690","journal-title":"Biomed Pharmacother"},{"key":"4007_CR86","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1124\/molpharm.120.000072","volume":"99","author":"JT Ortega","year":"2021","unstructured":"Ortega JT, Parmar T, Golczak M, Jastrzebska B (2021) Protective effects of flavonoids in acute models of light-induced retinal degeneration. Mol Pharmacol 99:60\u201377. https:\/\/doi.org\/10.1124\/molpharm.120.000072","journal-title":"Mol Pharmacol"},{"key":"4007_CR87","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archopht.1993.01090060049022","volume":"111","author":"EL Berson","year":"1993","unstructured":"Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W (1993) A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111:761\u2013772. https:\/\/doi.org\/10.1001\/archopht.1993.01090060049022","journal-title":"Arch Ophthalmol"},{"issue":"Suppl","key":"4007_CR88","doi-asserted-by":"publisher","first-page":"s221","DOI":"10.1016\/0098-2997(94)90032-9","volume":"15","author":"R Lodi","year":"1994","unstructured":"Lodi R, Iotti S, Scorolli L, Scorolli L, Bargossi AM, Sprovieri C, Zaniol P, Meduri R, Barbiroli B (1994) The use of phosphorus magnetic resonance spectroscopy to study in vivo the effect of coenzyme Q10 treatment in retinitis pigmentosa. Mol Aspects Med 15(Suppl):s221-230. https:\/\/doi.org\/10.1016\/0098-2997(94)90032-9","journal-title":"Mol Aspects Med"},{"key":"4007_CR89","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1023\/a:1019926122125","volume":"17","author":"H Pasantes-Morales","year":"2002","unstructured":"Pasantes-Morales H, Quiroz H, Quesada O (2002) Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis 17:183\u2013197. https:\/\/doi.org\/10.1023\/a:1019926122125","journal-title":"Metab Brain Dis"},{"key":"4007_CR90","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/archophthalmol.2011.2580","volume":"130","author":"EL Berson","year":"2012","unstructured":"Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Willett WC (2012) \u03c9-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 130:707\u2013711. https:\/\/doi.org\/10.1001\/archophthalmol.2011.2580","journal-title":"Arch Ophthalmol"},{"key":"4007_CR91","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaophthalmol.2013.147","volume":"131","author":"Y Rotenstreich","year":"2013","unstructured":"Rotenstreich Y, Belkin M, Sadetzki S, Chetrit A, Ferman-Attar G, Sher I, Harari A, Shaish A, Harats D (2013) Treatment with 9-cis \u03b2-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial. JAMA Ophthalmol 131:985\u2013992. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.147","journal-title":"JAMA Ophthalmol"},{"key":"4007_CR92","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/IAE.0000000000001542","volume":"38","author":"AM Mansour","year":"2018","unstructured":"Mansour AM, Sheheitli H, Kucukerdonmez C, Sisk RA, Moura R, Moschos MM, Lima LH, Al-Shaar L, Arevalo JF, Maia M, Foster RE, Kayikcioglu O, Kozak I, Kurup S, Zegarra H, Gallego-Pinazo R, Hamam RN, Bejjani RA, Cinar E, Erakg\u00fcn ET, Kimura A, Teixeira A (2018) Intravitreal dexamethasone implant in retinitis pigmentosa-related cystoid macular edema. Retina 38:416\u2013423. https:\/\/doi.org\/10.1097\/IAE.0000000000001542","journal-title":"Retina"},{"key":"4007_CR93","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jep.2019.03.023","volume":"236","author":"HH Chan","year":"2019","unstructured":"Chan HH, Lam HI, Choi KY, Li SZ, Lakshmanan Y, Yu WY, Chang RC, Lai JS, So KF (2019) Delay of cone degeneration in retinitis pigmentosa using a 12-month treatment with Lycium barbarum supplement. J Ethnopharmacol 236:336\u2013344. https:\/\/doi.org\/10.1016\/j.jep.2019.03.023","journal-title":"J Ethnopharmacol"},{"key":"4007_CR94","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1172\/JCI132990","volume":"130","author":"PA Campochiaro","year":"2020","unstructured":"Campochiaro PA, Iftikhar M, Hafiz G, Akhlaq A, Tsai G, Wehling D, Lu L, Wall GM, Singh MS, Kong X (2020) Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial. J Clin Invest 130:1527\u20131541. https:\/\/doi.org\/10.1172\/JCI132990","journal-title":"J Clin Invest"},{"key":"4007_CR95","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajo.2020.08.002","volume":"221","author":"X Kong","year":"2021","unstructured":"Kong X, Hafiz G, Wehling D, Akhlaq A, Campochiaro PA (2021) Locus-level changes in macular sensitivity in patients with retinitis pigmentosa treated with oral N-acetylcysteine. Am J Ophthalmol 221:105\u2013114. https:\/\/doi.org\/10.1016\/j.ajo.2020.08.002","journal-title":"Am J Ophthalmol"},{"key":"4007_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0022-510x(98)00296-2","volume":"162","author":"K Abe","year":"1999","unstructured":"Abe K, Matsuo Y, Kadekawa J, Inoue S, Yanagihara T (1999) Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): Evaluation by noninvasive tissue oximetry. J Neurol Sci 162:65\u201368. https:\/\/doi.org\/10.1016\/s0022-510x(98)00296-2","journal-title":"J Neurol Sci"},{"key":"4007_CR97","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","volume":"90","author":"Y Ohsawa","year":"2019","unstructured":"Ohsawa Y, Hagiwara H, Nishimatsu SI, Hirakawa A, Kamimura N, Ohtsubo H, Fukai Y, Murakami T, Koga Y, Goto YI, Ohta S, Sunada Y, KN01 Study Group (2019) Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry 90:529\u2013536. https:\/\/doi.org\/10.1136\/jnnp-2018-317964","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4007_CR98","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1007\/s00415-018-9057-7","volume":"265","author":"Y Koga","year":"2018","unstructured":"Koga Y, Povalko N, Inoue E, Nakamura H, Ishii A, Suzuki Y, Yoneda M, Kanda F, Kubota M, Okada H, Fujii K (2018) Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research. J Neurol 265:2861\u20132874. https:\/\/doi.org\/10.1007\/s00415-018-9057-7","journal-title":"J Neurol"},{"key":"4007_CR99","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mus.21758","volume":"42","author":"EI Glover","year":"2010","unstructured":"Glover EI, Martin J, Maher A, Thornhill RE, Moran GR, Tarnopolsky MA (2010) A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve 42:739\u2013748. https:\/\/doi.org\/10.1002\/mus.21758","journal-title":"Muscle Nerve"},{"issue":"Pt 9","key":"4007_CR100","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, Atawan A, Chattopadhyay S, Schubert M, Garip A, Kernt M, Petraki D, Rummey C, Leinonen M, Metz G, Griffiths PG, Meier T, Chinnery PF (2011) A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain 134(Pt 9):2677\u20132686. https:\/\/doi.org\/10.1093\/brain\/awr170","journal-title":"Brain"},{"key":"4007_CR101","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1161\/ATVBAHA.117.309225","volume":"37","author":"C P\u00e9rez-S\u00e1nchez","year":"2017","unstructured":"P\u00e9rez-S\u00e1nchez C, Aguirre M\u00c1, Ruiz-Lim\u00f3n P, \u00c1balos-Aguilera MC, Jim\u00e9nez-G\u00f3mez Y, Arias-de la Rosa I, Rodriguez-Ariza A, Fern\u00e1ndez-Del R\u00edo L, Gonz\u00e1lez-Reyes JA, Segui P, Collantes-Est\u00e9vez E, Barbarroja N, Velasco F, Sciascia S, Cecchi I, Cuadrado MJ, Villalba JM, L\u00f3pez-Pedrera C (2017) Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: a randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 37:1923\u20131932. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309225","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4007_CR102","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.redox.2015.01.009","volume":"4","author":"N Gueven","year":"2015","unstructured":"Gueven N, Woolley K, Smith J (2015) Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10. Redox Biol 4:289\u2013295. https:\/\/doi.org\/10.1016\/j.redox.2015.01.009","journal-title":"Redox Biol"},{"key":"4007_CR103","first-page":"343","volume-title":"Encyclopedia of nutritional supplements","author":"MT Murray","year":"1966","unstructured":"Murray MT (1966) Encyclopedia of nutritional supplements. Prima Publishing, Rocklin, CA, pp 343\u2013346"},{"key":"4007_CR104","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/cod.12393","volume":"73","author":"A Rizzi","year":"2015","unstructured":"Rizzi A, Nucera E, Buonomo A, Schiavino D (2015) Delayed hypersensitivity to alpha-lipoic acid: look at dietary supplements. Contact Dermatitis 73:49\u201367. https:\/\/doi.org\/10.1111\/cod.12393","journal-title":"Contact Dermatitis"},{"issue":"9","key":"4007_CR105","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.2337\/dc07-0689","volume":"30","author":"Y Ishida","year":"2007","unstructured":"Ishida Y, Ohara T, Okuno Y, Ito T, Hirota Y, Furukawa K, Sakaguchi K, Ogawa W, Kasugaet M (2007) Alpha-lipoic acid and insulin autoimmune syndrome. Diabetes Care 30(9):2240\u20132251. https:\/\/doi.org\/10.2337\/dc07-0689","journal-title":"Diabetes Care"},{"issue":"2","key":"4007_CR106","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3305\/nh.2015.31.2.7403","volume":"31","author":"PR Flor\u00eancio Mendes","year":"2015","unstructured":"Flor\u00eancio Mendes PR, dos Santos FD, da Silva PC, Pereira GH, da Silva Sim\u00f5es MO (2015) Effect of alpha lipoic acid on the blood cell count and iron kinetics in hypertensive patients. Nutr Hosp 31(2):883\u2013889. https:\/\/doi.org\/10.3305\/nh.2015.31.2.7403","journal-title":"Nutr Hosp"},{"key":"4007_CR107","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1055\/s-0034-1372622","volume":"226","author":"B Hadzik","year":"2014","unstructured":"Hadzik B, Grass H, Mayatepek E, Daldrup T, Hoehn T (2014) Fatal non-accidental alpha-lipoic acid intoxication in an adolescent girl. Klin Padiatr 226:292\u2013294. https:\/\/doi.org\/10.1055\/s-0034-1372622","journal-title":"Klin Padiatr"},{"issue":"3","key":"4007_CR108","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2337\/diacare.20.3.369","volume":"20","author":"D Ziegler","year":"1997","unstructured":"Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G (1997) Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20(3):369\u2013373. https:\/\/doi.org\/10.2337\/diacare.20.3.369","journal-title":"Diabetes Care"},{"key":"4007_CR109","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/187153008784534303","volume":"8","author":"S Salinthone","year":"2008","unstructured":"Salinthone S, Yadav V, Bourdette DN, Carr DW (2008) Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocr Metab Immune Disord Drug Targets 8:132\u2013142. https:\/\/doi.org\/10.2174\/187153008784534303","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"5","key":"4007_CR110","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/JCP.0b013e31829a83f5","volume":"33","author":"BP Brennan","year":"2013","unstructured":"Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG, Renshaw PF, Cohen BM (2013) A placebo-controlled trial of acetyl-l-carnitine and \u03b1-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol 33(5):627\u2013635. https:\/\/doi.org\/10.1097\/JCP.0b013e31829a83f5","journal-title":"J Clin Psychopharmacol"},{"key":"4007_CR111","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.ajkd.2016.08.041","volume":"69","author":"MB Rivara","year":"2017","unstructured":"Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, Linke L, Shen DD, Ikizler TA, Himmelfarb J (2017) Effect of coenzyme Q10 on biomarkers of oxidative stress and cardiac function in hemodialysis patients: the CoQ10 biomarker trial. Am J Kidney Dis 69:389\u2013399. https:\/\/doi.org\/10.1053\/j.ajkd.2016.08.041","journal-title":"Am J Kidney Dis"},{"key":"4007_CR112","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","volume":"71","author":"MF Beal","year":"2014","unstructured":"Beal MF, The Parkinson Study Group QE3 Investigators et al (2014) A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease-no evidence of benefit. JAMA Neurol 71:543\u2013552. https:\/\/doi.org\/10.1001\/jamaneurol.2014.131","journal-title":"JAMA Neurol"},{"key":"4007_CR113","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1212\/01.wnl.0000250355.28474.8e","volume":"68","author":"NINDS NET-PD Investigators","year":"2007","unstructured":"NINDS NET-PD Investigators (2007) A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology 68:20\u201328. https:\/\/doi.org\/10.1212\/01.wnl.0000250355.28474.8e","journal-title":"Neurology"},{"key":"4007_CR114","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/biof.5520320124","volume":"32","author":"T Hidaka","year":"2008","unstructured":"Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K (2008) Safety assessment of coenzyme Q10 (CoQ10). BioFactors 32:199\u2013208. https:\/\/doi.org\/10.1002\/biof.5520320124","journal-title":"BioFactors"},{"key":"4007_CR115","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10715760600617843","volume":"40","author":"HN Bhagavan","year":"2006","unstructured":"Bhagavan HN, Chopra RK (2006) Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40:445\u2013453. https:\/\/doi.org\/10.1080\/10715760600617843","journal-title":"Free Radic Res"},{"key":"4007_CR116","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/1541-4337.12539","volume":"19","author":"M Arenas-Jal","year":"2020","unstructured":"Arenas-Jal M, Su\u00f1\u00e9-Negre JM, Garc\u00eda-Montoya E (2020) Coenzyme Q10 supplementation: efficacy, safety, and formulation challenges. Compr Rev Food Sci Food Saf 19:574\u2013594. https:\/\/doi.org\/10.1111\/1541-4337.12539","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"4007_CR117","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/cells9030576","volume":"9","author":"L Poga\u010dnik","year":"2020","unstructured":"Poga\u010dnik L, Ota A, Ulrih NP (2020) An overview of crucial dietary substances and their modes of action for prevention of neurodegenerative diseases. Cells 9:576. https:\/\/doi.org\/10.3390\/cells9030576","journal-title":"Cells"},{"key":"4007_CR118","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s0140-6736(80)90384-0","volume":"2","author":"B Lacour","year":"1980","unstructured":"Lacour B, Di Giulio S, Chanard J, Ciancioni C, Haguet M, Lebkiri B, Basile C, Drueke T, Assan R, Funck-Brentano JL (1980) Carnitine improves lipid anomalies in haemodialysis patients. Lancet 2:763\u2013764. https:\/\/doi.org\/10.1016\/s0140-6736(80)90384-0","journal-title":"Lancet"},{"key":"4007_CR119","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ki.1990.289","volume":"38","author":"TA Golper","year":"1990","unstructured":"Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD (1990) Multicenter trial of l-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 38:904\u2013911. https:\/\/doi.org\/10.1038\/ki.1990.289","journal-title":"Kidney Int"},{"key":"4007_CR120","doi-asserted-by":"publisher","first-page":"114","DOI":"10.26442\/00403660.2019.01.000040","volume":"91","author":"ZM Sizova","year":"2019","unstructured":"Sizova ZM, Shikh EV, Makhova AA (2019) Significance of l-carnitine in internal medicine. Ter Arkh 91:114\u2013128. https:\/\/doi.org\/10.26442\/00403660.2019.01.000040","journal-title":"Ter Arkh"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-04007-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T07:18:47Z","timestamp":1638170327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-04007-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":120,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4007"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-04007-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,31]]},"assertion":[{"value":"19 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}